Bradley Monk - Prima Biomed Insider

Prima Biomed Ltd -- USA Stock  

USD 1.71  0.01  0.58%

Member of the Clinical Advisory Board

We currently do not have informatin regarding Bradley Monk. This executive tanure with Prima Biomed Ltd is not currenlty determined.
  Executive Since 2014      
61 2 8315 7003

Management Efficiency

The company has return on total asset (ROA) of (15.25) % which means that it has lost $15.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (30.29) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 4.42 M in liabilities with Debt to Equity (D/E) ratio of 21.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Prima Biomed Ltd has Current Ratio of 5.93 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Entity Summary

Prima BioMed Ltd. engages in the research, development, and commercialization of medical biotechnology solutions in Australia. Prima Biomed Ltd (PBMD) is traded on NASDAQ General Markets in USA. It is located in Sydney, NSW and employs 31 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Prima Biomed Ltd to your portfolio

Top Management

Prima Biomed Leadership Team
Pete Meyers, Director, MBA
Russell Howard, Director, Ph.D
Tom Bloomfield, Executive
Larisa Chisholm, Director
YueLing Wong, Chairman
Stuart Roberts, Executive
Frederic Triebel, Executive
Bradley Monk, Executive
Deanne Miller, Executive
Sharron Gargosky, Executive, Ph.D
Grant Chamberlain, Director
Lucy Turnbull, Chairman
Marc Voigt, CEO
Matthew Gregorowski, Executive

Stock Performance

Prima Biomed Performance Indicators